Integrated cancer therapy system manufacturer Varian Medical Systems has named Timothy E. Guertin president and chief operating officer and Dow R. Wilson as executive vice president.
"These promotions position Varian Medical Systems for continued growth into a multi-billion dollar enterprise while enhancing our management bench strength and leadership," said Richard M. Levy, chairman and CEO.
Guertin, a 30-year veteran with Varian, has been serving as executive vice president and chief operating officer since January. He will continue to report to Levy and have responsibility for guiding and directing the development, production, promotion, and sales of all Varian Medical Systems' products and services throughout the world. Guertin served as president of the Oncology Systems segment, which represents more than 80 percent of Varian's business, from 1990 until being named chief operating officer.
Wilson joined Varian as corporate vice president and president, Oncology Systems, in January. In his role as executive vice president, Wilson will continue to have the same responsibilities and report to Guertin. Wilson came to Varian from GE where he had been serving as CEO of the $2.5 billion GE Healthcare-Information Technologies business. While at GE, Wilson managed several operations including global businesses in CT, X-ray, and functional imaging.